#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Hepatic cirrhosis Heavy menstrual bleeding Small cell lung cancer limited stage Polycythaemia vera Diabetes insipidus Desmoplastic small round cell tumour Cryoglobulinaemia Arginase deficiency Prader-Willi syndrome Pouchitis Krabbe's disease Chondrosarcoma Chronic myeloid leukaemia T-cell lymphoma More trials…

    Learn about Rare Diseases

    Pulmonary sarcoidosis – Trials in Disease Progressive supranuclear palsy – Treatment Testicular leiomyosarcoma – Diagnostics Haemophilia A without inhibitors – Life with Disease Myxofibrosarcoma – Trials in Disease Alternating hemiplegia of childhood – Treatment Urea cycle disorder Epidermolysis bullosa – Diagnostics Leiomyosarcoma recurrent Waldenstrom’s macroglobulinaemia recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TRIGLYCERIDES MEDIUM CHAIN [14C] DC-806 Colistin Sulfate IDOR-1117-2520C Formoterol Fumarate Dihydrate Liraglutide Minoxidil Olmesartan Medoxomil Ribitol Sufentanil Citrate Art6043 Eribulin Obinutuzumab Ketoprofen Sapropterin Dihydrochloride PETHIDINE HYDROCHLORIDE Trospium Chloride Sodium Butyrate Neflamapimod Escitalopram More therapies…

    Learn about Your Condition

    Intervertebral disc protrusion Choroidal neovascularisation Osteomyelitis acute Apathy Neoplasm Skin candida Follicular thyroid cancer Spinal cord injury Sexual dysfunction Psychotic behaviour Oesophageal carcinoma Pyrexia Mucopolysaccharidosis I Osteosarcoma recurrent Nodular melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopitaux Universitaires Pitie Salpetriere

Hopitaux Universitaires Pitie Salpetriere

47 Boulevard De L Hopital, Paris, 75651, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Stopping Disease-Modifying Therapies in Inactive Secondary Progressive Multiple Sclerosis Patients Over 50 Using Glatiramer Acetate and Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Secondary progressive multiple sclerosis
    Investigated Drugs:
    • Dimethyl Fumarate
    • Interferon Beta-1A
    • Interferon Beta-1B
    France

  • Study of Avapritinib for Patients with Indolent Systemic Mastocytosis Not Adequately Managed by Standard Therapy

    Not recruiting

    2 1
    Investigated Drugs:
    • Avapritinib
    Belgium Denmark France Germany Italy The Netherlands +3

  • Study Comparing Selinexor, Pomalidomide, and Dexamethasone with Elotuzumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Selinexor
    • Dexamethasone
    • Dexamethasone Sodium Phosphate
    France Germany Greece Italy The Netherlands Spain

  • Study of OSE2101 vaccine alone or with pembrolizumab as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer after chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Mps-102
    • Mps-103
    Belgium France Germany

  • Study on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus

    Not recruiting

    3 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Cenerimod
    Bulgaria France Greece Poland Romania

  • Study on the Effectiveness of Sodium Chloride and Sodium Citrate in Intensive Care Patients Undergoing Continuous Kidney Purification

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Thrombosis prophylaxis
    Investigated Drugs:
    • Sodium Citrate
    • Sodium Chloride
    France

  • Study on the Safety and Effectiveness of Zilovertamab Vedotin for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Zilovertamab Vedotin
    Czechia Estonia France Greece Italy Norway +3

  • Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Asundexian
    • Apixaban
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

  • Study on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Monkeypox
    Investigated Drugs:
    • Tecovirimat
    Belgium France Ireland Italy The Netherlands Norway +2

  • Study of AMG 732 injection compared to placebo in patients with moderate to severe thyroid eye disease

    Not recruiting

    2 1
    Investigated Drugs:
    • AMG 732
    France Germany Greece Italy Poland Spain
Previous Page
1 … 17 18 19 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!